S. Al-Salam, C. Sharma, B. Afandi, BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates. PLoS One 15(4), e0231341 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J.A. Sosa, R. Udelsman, Papillary thyroid cancer. Surg. Oncol. Clin. North Am. 15(3), 585–601 (2006)

Article  Google Scholar 

C.C. Juhlin, O. Mete, Z.W. Baloch, The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading. Endocr. Related Cancer. ERC-22 (2022)

R.W. Randle, N.M. Bushman, J. Orne, C.J. Balentine, E. Wendt, M. Saucke et al. Papillary thyroid cancer: the good and bad of the “good cancer”. Thyroid. Off. J. Am. Thyroid. Assoc. 27(7), 902–907 (2017)

Article  Google Scholar 

J.P. Brito, I.D. Hay, J.C. Morris, Low risk papillary thyroid cancer. BMJ (Clin. Res. ed.) 348, g3045 (2014)

Google Scholar 

I. Petrini, R.L. Cecchini, M. Mascaró, I. Ponzoni, J.A. Carballido, Papillary thyroid carcinoma: a thorough bioinformatic analysis of gene expression and clinical data. Genes 14(6), 1250 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Hedayati, S. Rajabi, A. Nikzamir, Papillary thyroid cancer-promoting activities of combined oral contraceptive components. Galen. Med. J. 9, e1648 (2020)

Article  PubMed  PubMed Central  Google Scholar 

E. Kyrodimos, A. Chrysovergis, N. Mastronikolis, G. Papanastasiou, E. Tsiambas, D. Spyropoulou, et al. The landscape of single nucleotide polymorphisms in papillary thyroid carcinoma. Cancer Diagn Progn. 3(1), 26 (2023).

X. Nie, J. Shang, W. Wang, TERT genetic polymorphism rs2736100 is associated with an aggressive manifestation of papillary thyroid carcinoma. Front. Surg. 9, 1019180 (2023)

Article  PubMed  PubMed Central  Google Scholar 

J.I. Staubitz, C. Müller, A. Heymans, C. Merten, B. Roos, A. Poplawski et al. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis. BJS Open 7(3), zrad029 (2023)

Article  PubMed  PubMed Central  Google Scholar 

M. Xing, BRAF mutation in thyroid cancer. Endocr.-Relat. Cancer Endocr. Relat. Cancer 12(2), 245–262 (2005)

Article  CAS  PubMed  Google Scholar 

S. Li, A. Balmain, C.M. Counter, A model for RAS mutation patterns in cancers: finding the sweet spot. Nat. Rev. Cancer 18(12), 767–777 (2018)

Article  CAS  PubMed  Google Scholar 

S.A. Razavi, P. Salehipour, H. Gholami, S. Sheikholeslami, M. Zarif-Yeganeh, P. Yaghmaei et al. New evidence on tumor suppressor activity of PTEN and KLLN in papillary thyroid carcinoma. Pathol. Res. Pract. 225, 153586 (2021)

Article  CAS  PubMed  Google Scholar 

J. Lim, H.S. Lee, J. Park, K.-S. Kim, S.-K. Kim, Y.-W. Cho, Y.S. Song, Different molecular phenotypes of progression in BRAF-and RAS-like papillary thyroid carcinoma. Endocrinol. Metab. 38(4), 445–454 (2023)

Article  CAS  Google Scholar 

T. Wang, J. Shi, L. Li, X. Zhou, H. Zhang, X. Zhang et al. Single-cell transcriptome analysis reveals inter-tumor heterogeneity in bilateral papillary thyroid carcinoma. Front. Immunol. 13, 840811 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Lu, J.R. Wang, Y.C. Henderson, S. Bai, J. Yang, M. Hu et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J. Clin. Investig. 133(11), e169653 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W.J. Pereira, F.M. Almeida, D. Conde, K. Balmant, P. Triozzi, H. Schmidt et al. Asc-Seurat: analytical single-cell Seurat-based web application. BMC Bioinforma. 22, 1–14 (2021)

Article  Google Scholar 

T. Stuart, A. Butler, P. Hoffman, C. Hafemeister, E. Papalexi, W.M. Mauck et al. Comprehensive integration of single-cell data. Cell 177(7), 1888–902. e21 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Butler, P. Hoffman, P. Smibert, E. Papalexi, R. Satija, Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36(5), 411–420 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Hao, T. Stuart, M.H. Kowalski, S. Choudhary, P. Hoffman, A. Hartman et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42(2), 293–304 (2024)

Article  CAS  PubMed  Google Scholar 

M. Uhlén, L. Fagerberg, B.M. Hallström, C. Lindskog, P. Oksvold, A. Mardinoglu et al. Tissue-based map of the human proteome. Science 347(6220), 1260419 (2015)

Article  PubMed  Google Scholar 

C. Hu, T. Li, Y. Xu, X. Zhang, F. Li, J. Bai et al. CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 51(D1), D870–D876 (2023)

Article  CAS  PubMed  Google Scholar 

M. Zarkesh, A. Zadeh-Vakili, F. Azizi, S.A. Fanaei, F. Foroughi, M. Hedayati, The association of BRAF V600E mutation with tissue inhibitor of metalloproteinase-3 expression and clinicopathological features in papillary thyroid cancer. Int. J. Endocrinol. Metab. 16(2), e56120 (2018)

Article  PubMed  PubMed Central  Google Scholar 

S.A. Razavi, M.H. Modarressi, P. Yaghmaei, S.M. Tavangar, M. Hedayati, Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Endocrine 57, 428–435 (2017)

Article  CAS  PubMed  Google Scholar 

J.-F. Hang, J.-Y. Chen, P.-C. Kuo, H.-F. Lai, T.-L. Lee, S.-K. Tai et al. A shift in molecular drivers of papillary thyroid carcinoma following the 2017 World Health Organization Classification: characterization of 554 consecutive tumors with emphasis on BRAF-negative cases. Mod. Pathol. 36(9), 100242 (2023)

Article  PubMed  Google Scholar 

S.-Y. Kim, S.-J. Shin, D.-G. Lee, H.-J. Yun, S.-M. Kim, H. Chang et al. Clinicopathological and genetic characteristics of patients of different ages with diffuse sclerosing variant papillary thyroid carcinoma. Cancers 15(12), 3101 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

C. Eloy, J. Santos, P. Soares, M. Sobrinho-Simões, The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Virchows Arch. 459(3), 265–276 (2011)

Article  CAS  PubMed  Google Scholar 

Y.C. Henderson, T.D. Shellenberger, M.D. Williams, A.K. El-Naggar, M.J. Fredrick, K.M. Cieply, G.L. Clayman, High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 15(2), 485–491 (2009)

Article  CAS  Google Scholar 

M. Rivera, J. Ricarte-Filho, J. Knauf, A. Shaha, M. Tuttle, J.A. Fagin, R.A. Ghossein, Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod. Pathol. 23(9), 1191–1200 (2010)

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Hong, Y. Xie, Z. Cheng, J. Li, Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability. Oncogene 41(47), 5121–5132 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

V. Veschi, A. Turdo, Recapitulating thyroid cancer histotypes through engineering embryonic stem cells. Nat. Commun. 14(1), 1351 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Matsuse, T. Yabuta, V. Saenko, M. Hirokawa, E. Nishihara, K. Suzuki et al. TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors. Sci. Rep. 7, 41752 (2017)

Article  CAS  PubMed  PubMed Central